Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sphere of biopharmaceuticals, featuring promising enhancements throughout a variety of medical and industrial purposes. With its structural similarity to naturally derived human serum albumin, OsrHSA offers a safer, far more reliable substitute for therapeutic use, sp